Reasons for compliance or noncompliance with advice to test for hepatitis C via an internetmediated blood screening service: a qualitative study
- Modelling the past, current and future HCV burden in France: detailed analysis and perspectives. Deuffic-Burban, Sylvie; Mathurin, Philippe; Valleron, Alain-Jacques // Statistical Methods in Medical Research;Jun2009, Vol. 18 Issue 3, p233
Two national HCV projections have been published in France which assumed that a part of observed hepatocellular carcinoma (HCC) deaths is a consequence of HCV epidemic. They applied the back-calculation method, in combination with a Markov model, to reconstruct the past history of HCV infection...
- Global control of hepatitis C: where challenge meets opportunity. Thomas, David L // Nature Medicine;Jul2013, Vol. 19 Issue 7, p850
We are entering an important new chapter in the story of hepatitis C virus (HCV) infection. There are clear challenges and opportunities. On the one hand, new HCV infections are still occurring, and an estimated 185 million people are or have previously been infected worldwide. Most HCV-infected...
- Hepatitis C Virus Prevention, Care, and Treatment: From Policy to Practice. Ward, John W.; Valdiserri, Ron O.; Koh, Howard K. // Clinical Infectious Diseases;Jul2012 Supplement 1, Vol. 55 Issue suppl_1, pS58
The prevention of hepatitis C virus (HCV) infection and associated health conditions (eg, cirrhosis and hepatocellular carcinoma) is a public health priority in the United States. Hepatitis C virusâ€“related morbidity and mortality is increasing at a time when the advent of highly effective...
- HCV protein causes cancer. // AIDS Patient Care & STDs;Dec98, Vol. 12 Issue 12, p943
Discusses findings of Japanese researchers that the hepatitis C virus (HVC) core protein induces hepatocellular carcinoma. Development of hepatic steatosis in laboratory mice as histologic feature of chronic hepatitis C; Characteristics of mice carrying HCV envelope genes.
- Incomplete response of interferon treatment has an important role for the prevention of hepatocellular carcinoma. Hayashi, Norio // Journal of Gastroenterology;1999, Vol. 34 Issue 5, p655
Editorial. Focuses on the incidence of hepatocellular carcinoma (HCC) in Japan. Incidence rate of HCC in cirrhotic patients with antibodies to hepatitis C virus (HCV); Treatment of HCV.
- Iron, hepatitis C virus, and hepatocellular carcinoma: iron reduction preaches the gospel for chronic hepatitis C. Fujita, Naoki; Takei, Yoshiyuki // Journal of Gastroenterology;Nov2007, Vol. 42 Issue 11, p923
The article discusses various reports publishes within the issue, including one on chronic hepatitis C virus and another on iron reduction.
- Treatment of hepatitis C. The 2002 French consensus. Dhumeaux, D.; marcellin, P.; Lerebours, E. // Gut;Dec2003, Vol. 52 Issue 12, p1784
Chronic infection by hepatitis C virus (HCV) affects 170 million people worldwide. In European countries the overall prevalence in adults ranges from 1% to 2%, and more than five million Europeans are thus infected. The high prevalence of HCV infection, together with the risk of severe...
- Regulation of hepatic innate immunity by hepatitis C virus. Horner, Stacy M; Gale, Michael // Nature Medicine;Jul2013, Vol. 19 Issue 7, p879
Hepatitis C virus (HCV) is a global public health problem involving chronic infection of the liver, which can cause liver disease and is linked with liver cancer. Viral innate immune evasion strategies and human genetic determinants underlie the transition of acute HCV infection to viral...
- Role of different regions of the hepatitis C virus genome in the therapeutic response to interferon-based treatment. Khaliq, Saba; Latief, Noreen; Jahan, Shah // Archives of Virology;Jan2014, Vol. 159 Issue 1, p1
Hepatitis C virus (HCV) is considered a significant risk factor in HCV-induced liver diseases and development of hepatocellular carcinoma (HCC). Nucleotide substitutions in the viral genome result in its diversification into quasispecies, subtypes and distinct genotypes. Different genotypes vary...